Finally, we demonstrate that, in MDA-MB-231, a Bcl-xL-dependent breast cancer cell model, endogenous Bcl-xL can exploit this mechanism to suppress IP3R activity and to counteract Ca2+-driven apoptosis. The gene discussed is ITPR3; the disease is breast cancer.